Skip to content

Animal Science Products, Inc. v. Hebei Welcome Pharmaceutical Co. Ltd.

Petition for certiorari denied on October 3, 2022

Docket No. Op. Below Argument Opinion Vote Author Term
21-1283 2nd Cir. N/A N/A N/A N/A OT 2022

Issue: (1) Whether, despite the Supreme Court"s "well established" interpretation of the Sherman Act, U.S. courts may reinterpret the same text of that act case by case using a discretionary 10-factor balancing test under the doctrine of prescriptive comity; and (2) whether a court interpreting the meaning of foreign law under Federal Rule of Civil Procedure 44.1 is limited to the "face" of written legal materials, as the decision below held, or may also consider evidence as to how foreign law is implemented and enforced that would be relevant to the interpretive inquiry in the foreign legal system.